Agenda: Day 2

All session times are in Eastern Time (ET)

There are no agenda items with this track

8:00 am

8:00 am

Registration & Breakfast

  • Start your day off right and make connections with market access leaders
  • Interact with your peers, discuss best practices and share innovative strategies
  • Gather essential content and get exclusive offers at sponsor booths

9:00 am

9:00 am

Welcome From Your Chair

Gain insight into today’s sessions so you can get the most out of your experience and maximize your value.

9:10 am

9:10 am

INSIDER FIRESIDE CHAT

Is a two-tiered system the answer to help closing the gap?

What can we glean from a frank discussion among a Health Canada representative, a manufacturer and a patient advocate? Everyone knows governments are stretched to provide adequate outcomes for those uninsured; is it time for those who can afford it to pay their way and let public payors help those who can’t help themselves?

9:45 am

9:45 am

FIRESIDE CHAT: CADTH UPDATE

Are We Increasing The Percentage Of Submissions Approved First Time Around, or Not?

How much time in spent revising new drug submissions when you add it all up? Accurately interpreting the impact of these learnings is fundamental to your company’s bottom line. Source intelligence to:

  • Gain a comprehensive understanding of the information requirements for drug submissions to CADTH
  • Adopt best practices to better manage your product submissions under the revised process
  • Navigate through the changes seamlessly and efficiently

Position your product for a prosperous journey through the updated CADTH review process

10:30 am

10:30 am

Morning Break

  • Engage with conference speakers and fellow attendees
  • Secure new business contacts and discuss crucial developments in market access
  • Exchange innovations and ideas

11:00 am

11:00 am

INDUSTRY EXPERT: REAL-WORLD EVIDENCE

Discover How Real-World Evidence is Impacting Drug Development and Approval

It is now commonly required for governments, industry players and other stakeholders to provide quality data to support their submissions for reimbursement. This was evident with the expedited approval of the COVID-19 vaccines. Improve the value proposition of your medicines with new approaches using Real-World Evidence (RWE). Source practical tips to:

  • Enhance the efficacy of your medications on individual patient outcomes.
  • Evaluate the impact of RWE on overall population health of patients taking your medication.
  • Partner with stakeholders to access data pertinent to reimbursement.

Prove and improve the value, efficacy and impact of your medications with RWE.

11:30 am

11:30 am

PRICING OUTLOOK 2022-2023

IS PMPRB RELEVANT, OR NOT?

The PMPRB considers itself to be in a holding pattern due to the delays in the rollout of the new regime. As such, the two stated priorities for the coming year are the same as they were in the 2021-22 Departmental Plan: (1) to implement the new pricing framework and begin evaluating its impact; and (2) to support the federal government’s high-level priorities for the future of pharmaceutical management in Canada.

12:00 pm

12:00 pm

Networking Lunch

  • Expand your network and make connections that last beyond the event
  • Visit the exhibitor hall and pose your toughest questions to leading consultants
  • Enjoy great food and service while engaging with your pharma colleagues

1:30 pm

1:30 pm

INTERNATIONAL REFERENCE PRICING (IRP) A YEAR LATER:

AN OVERVIEW AND OUTLOOK FOR IRP IN NORTH AMERICA

IRP is a frequently tossed-around term used in reference to controlling rising drug prices in both Canada and the US. Leverage an in-depth understanding of the history and future consequences for your brands/products. Gain critical insights including:

  • Incorporating IRP, the absence of price transparency and role of confidential agreements & patient access schemes
  • Informing yourself via a case study how the new basket of 11 reference countries is intended to lower Canadian drug prices to OECD median
  • Evaluating the proposed US IRP regulatory proposals and their potential for implementation in current political environment

Assess the impact of IRP on your upcoming launch sequencing & patient access

2:00 pm

2:00 pm

INDUSTRY EXPERT: METRIC ANALYSIS

Future-Proof Your Company with Market Access Metrics & Trends for 2022 and Beyond

The pharmaceutical industry has changed significantly over the past decade. This change will only continue to accelerate, affecting nearly the entire market from drug development to access. Prepare your company to adapt to changing market access realities with data-driven insights. Develop an action plan to:

  • Identify the factors likely to impact the timeline of your products’ development to ensure a seamless launch.
  • Analyze how market trends are shaping your future opportunities.
  • Assess how the increasing digitalization of healthcare will impact your relationships with patients and health professionals.

Bolster your market access strategy for the next decade with a data-driven approach.

2:30 pm

2:30 pm

Afternoon Networking Break

  • Engage with conference speakers and fellow attendees
  • Secure new business contacts and discuss crucial developments in market access
  • Exchange innovations and ideas

4:00 pm

4:00 pm

Summary and Closing Comments from your Host

Review the key solutions and takeaways from today’s sessions. Source a summary of action points to implement in your work.

4:15 pm

4:15 pm

Conference Adjourns

Get the latest news

*Privacy Policy